DE60011638D1 - POLYMORPHE DES N-METHYL-N-(3-(2-THIENYLCARBONYL)-PYRAZOL[1,5-a]PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSTELLUNGEN UND DIESBEZÜGLICHE METHODEN - Google Patents

POLYMORPHE DES N-METHYL-N-(3-(2-THIENYLCARBONYL)-PYRAZOL[1,5-a]PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSTELLUNGEN UND DIESBEZÜGLICHE METHODEN

Info

Publication number
DE60011638D1
DE60011638D1 DE60011638T DE60011638T DE60011638D1 DE 60011638 D1 DE60011638 D1 DE 60011638D1 DE 60011638 T DE60011638 T DE 60011638T DE 60011638 T DE60011638 T DE 60011638T DE 60011638 D1 DE60011638 D1 DE 60011638D1
Authority
DE
Germany
Prior art keywords
thienylcarbonyl
compilations
polymorph
pyrimidin
pyrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60011638T
Other languages
English (en)
Other versions
DE60011638T2 (de
Inventor
William J Thiele
Patrick B O'donnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurocrine Biosciences Inc
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of DE60011638D1 publication Critical patent/DE60011638D1/de
Application granted granted Critical
Publication of DE60011638T2 publication Critical patent/DE60011638T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60011638T 1999-09-02 2000-09-01 POLYMORPHE DES N-METHYL-N-(3-(2-THIENYLCARBONYL)-PYRAZOL[1,5-a]PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSTELLUNGEN UND DIESBEZÜGLICHE METHODEN Expired - Lifetime DE60011638T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38952499A 1999-09-02 1999-09-02
US42162099A 1999-10-19 1999-10-19
PCT/US2000/024051 WO2001015700A1 (en) 1999-09-02 2000-09-01 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO

Publications (2)

Publication Number Publication Date
DE60011638D1 true DE60011638D1 (de) 2004-07-22
DE60011638T2 DE60011638T2 (de) 2004-10-21

Family

ID=27012737

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60011638T Expired - Lifetime DE60011638T2 (de) 1999-09-02 2000-09-01 POLYMORPHE DES N-METHYL-N-(3-(2-THIENYLCARBONYL)-PYRAZOL[1,5-a]PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSTELLUNGEN UND DIESBEZÜGLICHE METHODEN

Country Status (26)

Country Link
EP (2) EP1477169A1 (de)
JP (1) JP4592241B2 (de)
KR (1) KR20020035585A (de)
CN (2) CN1331865C (de)
AP (1) AP1631A (de)
AT (1) ATE269082T1 (de)
AU (2) AU769856B2 (de)
BR (1) BR0014459A (de)
CA (1) CA2382588C (de)
CZ (1) CZ2002783A3 (de)
DE (1) DE60011638T2 (de)
DK (1) DK1214075T3 (de)
EA (1) EA004706B1 (de)
ES (1) ES2222920T3 (de)
HK (1) HK1047407B (de)
HU (1) HUP0202698A3 (de)
IL (2) IL148242A0 (de)
MX (1) MXPA02002314A (de)
NO (1) NO322752B1 (de)
NZ (1) NZ517298A (de)
OA (1) OA12200A (de)
PL (1) PL353362A1 (de)
PT (1) PT1214075E (de)
SK (1) SK2782002A3 (de)
TR (1) TR200200534T2 (de)
WO (1) WO2001015700A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003268212B2 (en) * 2002-08-26 2008-08-14 Neurocrine Biosciences, Inc. Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-YL}phenyl)acetamide and compositions and methods related thereto
WO2004110454A1 (ja) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP1918290A1 (de) 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymprph B von N-{2-Fluor-5-[3-(thiophen-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methyl-acetamid
EP1956021A1 (de) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Verfahren zur Herstellung von Crystallin pyrazol[1,5-a]pyrimidin Verbindung
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
WO2010109480A2 (en) * 2009-03-24 2010-09-30 Glenmark Generics Limited Processes for the preparation of indiplon and intermediates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
DE19975048I2 (de) * 1985-05-13 2001-06-13 American Cyanamid Co 7-(3-Disubstituierte Amino)phenyl pyrazolo 1,5-a -pyrimidine
US5421422A (en) * 1993-11-19 1995-06-06 Boretec Inc Roller cutter mount for tunneling machine

Also Published As

Publication number Publication date
OA12200A (en) 2006-05-09
EA004706B1 (ru) 2004-06-24
EP1214075B1 (de) 2004-06-16
JP4592241B2 (ja) 2010-12-01
CN1331865C (zh) 2007-08-15
EP1477169A1 (de) 2004-11-17
CA2382588A1 (en) 2001-03-08
HK1047407B (zh) 2004-12-24
AP2002002428A0 (en) 2002-03-31
AU769856B2 (en) 2004-02-05
HUP0202698A3 (en) 2004-12-28
CA2382588C (en) 2008-11-25
AU2004201356A1 (en) 2004-04-29
ES2222920T3 (es) 2005-02-16
EP1214075A1 (de) 2002-06-19
AU6949100A (en) 2001-03-26
HUP0202698A2 (hu) 2002-12-28
NZ517298A (en) 2004-01-30
WO2001015700A9 (en) 2002-09-12
EP1214075A4 (de) 2003-05-02
CZ2002783A3 (cs) 2004-01-14
CN1680376A (zh) 2005-10-12
TR200200534T2 (tr) 2002-06-21
SK2782002A3 (en) 2003-04-01
HK1047407A1 (en) 2003-02-21
WO2001015700A1 (en) 2001-03-08
IL148242A (en) 2006-12-10
PL353362A1 (en) 2003-11-17
AP1631A (en) 2006-07-12
NO322752B1 (no) 2006-12-04
CN1198824C (zh) 2005-04-27
DE60011638T2 (de) 2004-10-21
JP2003508440A (ja) 2003-03-04
ATE269082T1 (de) 2004-07-15
CN1374866A (zh) 2002-10-16
IL148242A0 (en) 2002-09-12
PT1214075E (pt) 2004-11-30
EA200200320A1 (ru) 2002-08-29
DK1214075T3 (da) 2004-10-25
NO20021041D0 (no) 2002-03-01
NO20021041L (no) 2002-04-03
BR0014459A (pt) 2002-07-16
KR20020035585A (ko) 2002-05-11
MXPA02002314A (es) 2002-08-12

Similar Documents

Publication Publication Date Title
DE60001451T2 (de) 1,4-diazabicyclo[3.2.2]nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
ATE420645T1 (de) Stabiles polymorph des n-(3-ehynylphenylamino)-6, 7-bis(2-methoxyethoxy)-4-chinazolin-hydrochlori s,verfahren zu seiner herstellung und seine pharmazeutische anwendung
DE602004022946D1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
IL173252A0 (en) N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO
DE60133973D1 (de) L-Arginin produzierendes Escherichia coli und Verfahren zur Herstellung von L-Arginin
AU7240201A (en) Aza- and polyazanthranyl amides and their use as medicaments
NO20050615L (no) NY POLYMORF AV N-METYL-N-(3-{3-[2-TIENYLKARBONYL]-PYRAZOL-[1,5-alfa]-PYRIMIDIN-7-YL}FENYL)ACETAMID OG PREPARAT OG ANVENDELSER RELATERT DERTIL
IL155966A0 (en) Benzothiophene derivative compounds, process of preparation and use thereof
WO2002100442A3 (en) Use of l-polynucleotides and derivatives thereof for in vivo imaging
DE60103054D1 (de) Phenyloxazol-1,4-diazabicyclo[3.2.2]nonanderivate, ihre herstellung und ihre therapeutische verwendung
DE60100621D1 (de) 4-heteroaryl-1,4-diazabicyclo 3.2.2.]nonane, ihre herstellung und ihre therapeutische anwendung
DE60009804D1 (de) Heteroaryl-substituierte Pyrrole, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung
DE60011638D1 (de) POLYMORPHE DES N-METHYL-N-(3-(2-THIENYLCARBONYL)-PYRAZOL[1,5-a]PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSTELLUNGEN UND DIESBEZÜGLICHE METHODEN
PL374176A1 (en) Process for purifying n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process
GB0112812D0 (en) Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
PL372942A1 (en) Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
DE69808921D1 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
DE60120787D1 (de) Kombiniertes wirbelbett- und kohlenstaubverbrennungsverfahren
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60201007D1 (de) Synthese zur herstellung von 1,4-diketopyrrolo[3,4-c]pyrrolen
ATE237584T1 (de) Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung
ATE516267T1 (de) Vefahren zur herstellung von lactamen
DE60017330D1 (de) Verfahren zur Herstellung von 3-pyridylsulphonylpyrazolo[4,3-d]pyrimidin-7-one und Zwischenprodukte
AU3290200A (en) Treatment agents for textiles, method of producing same and their use
DE10085242D2 (de) Bewehrungsmaterial, Verfahren zu seiner Herstellung und Anwendung des Bewehrungsmaterials

Legal Events

Date Code Title Description
8364 No opposition during term of opposition